| 2013 | A cross-sectional study of factors related to gastrointestinal drug use in Korean adolescents | 곽혜선; 이병구; 이정연; 배승진 | Article |
| 2020 | Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries? | 배승진 | Article |
| 2020 | Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea | 배승진; 이동환; 손경복 | Article |
| 2020 | The Burden of Cervical Cancer in Korea: A Population-Based Study | 배승진; 이동환; 손경복 | Article |
| 2015 | Relationship of ceramide-, and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins | 배승진; 임경민 | Letter |
| 2014 | Sourcing quality-of-life weights obtained from previous studies: Theory and reality in Korea | 배승진 | Review |
| 2021 | The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future | 배승진 | Article |
| 2019 | Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study | 배승진; 손경복 | Article |
| 2019 | A dynamic DNA nanostructure with switchable and size-selective molecular recognition properties | 이혁진; 박소정; 김찬진 | Article |
| 2022 | The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS | 배승진 | Article |
